The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) continuously monitor post-marketing surveillance data for GLP-1 medicines
The company's semaglutide, marketed under brands such as Wegovy for weight loss and Ozempic for diabetes, has been a market leader and pioneer
Yes, most cases of shedding are temporary and improve with proper nutrition, reduced stress, and lifestyle changes
The results were statistically significant
Commonly prescribed weight loss medications include: Orforglipron (Foundayo) Foundayo is the brand name for orforglipron, a small-molecule, non-peptide GLP-1 receptor agonist
Like any addict, going cold turkey is a real challenge. Separate research published in Obesity Reviews found a lack of robust evidence surrounding nutritional advice and support for people on semaglutide and tirzepatide